Analysis of clinical outcomes of pregnant patients treated with nirmatrelvir and ritonavir for acute SARS-CoV-2 infection
WM Garneau, K Jones-Beatty, MO Ufua… - JAMA Network …, 2022 - jamanetwork.com
Importance Pregnant people are at increased risk of poor outcomes due to infection with
SARS-CoV-2, and there are limited therapeutic options available. Objective To evaluate the
clinical outcomes associated with nirmatrelvir and ritonavir used to treat SARS-CoV-2
infection in pregnant patients. Design, Setting, and Participants This case series included
pregnant patients who were diagnosed with SARS-CoV-2 infection, received nirmatrelvir
and ritonavir, and delivered their offspring within the Johns Hopkins Health System between …
SARS-CoV-2, and there are limited therapeutic options available. Objective To evaluate the
clinical outcomes associated with nirmatrelvir and ritonavir used to treat SARS-CoV-2
infection in pregnant patients. Design, Setting, and Participants This case series included
pregnant patients who were diagnosed with SARS-CoV-2 infection, received nirmatrelvir
and ritonavir, and delivered their offspring within the Johns Hopkins Health System between …